ConductScience.org, home

Paper748375

Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.

Brandeis WE and 4 others. J Clin Invest, 1978. Cited by 52 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease. Papers, record 748375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/748375

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.
PubMed
Journal
J Clin Invest
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
2.06
iCite
Revised in PubMed
2018-11-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brandeis WEW E
2Helson LL
3Wang YY
4Good RAR A
5Day NKN K

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigen-Antibody ComplexMajor topic
NeuroblastomaMajor topic
Child
Complement C1
Complement C3
Complement System Proteins
Humans
Prognosis
Retrospective Studies

Source PubMed

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,099,453IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS.Am J Pathol1963https://conductscience.org/library/papers/14099453PubMed
214,085,892NEUROBLASTOMA: AN EVALUATION OF ITS NATURAL HISTORY AND THE EFFECTS OF THERAPY, WITH PARTICULAR REFERENCE TO TREATMENT BY MASSIVE DOSES OF VITAMIN B12.Arch Dis Child1963https://conductscience.org/library/papers/14085892PubMed
4559,938Binding of soluble immune complexes in serum of patients with Hodgkin's disease to tissue cultures derived from the tumor.N Engl J Med1977https://conductscience.org/library/papers/559938PubMed
571,194The prognostic value of acute phase reactants in patients with neuroblastoma.Cancer1977https://conductscience.org/library/papers/71194PubMed
6136,325Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementaemia in chronic lymphocytic leukaemia (CLL).Clin Exp Immunol1976https://conductscience.org/library/papers/136325PubMed
7325,016Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.J Clin Invest1977https://conductscience.org/library/papers/325016PubMed
8323,505The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.J Natl Cancer Inst1977https://conductscience.org/library/papers/323505PubMed
9268,330Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.J Clin Invest1977https://conductscience.org/library/papers/268330PubMed
10884,444Circulating immune complexes in patients with breast cancer.Br Med J1977https://conductscience.org/library/papers/884444PubMed
11853,126Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.J Clin Invest1977https://conductscience.org/library/papers/853126PubMed
121,070,156[Circulating immune complexes in human leukemias].Schweiz Med Wochenschr1976https://conductscience.org/library/papers/1070156PubMed
135,288,389Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.Proc Natl Acad Sci U S A1971https://conductscience.org/library/papers/5288389PubMed
144,364,717Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.Int J Cancer1973https://conductscience.org/library/papers/4364717PubMed
154,276,372Subclinical immune complex nephritis in patients with Hodgkin's disease.Cancer Res1974https://conductscience.org/library/papers/4276372PubMed
164,468,198C3 proactivator (C3PA) as an acute phase reactant.Clin Exp Immunol1974https://conductscience.org/library/papers/4468198PubMed
174,377,147Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma.Intervirology1974https://conductscience.org/library/papers/4377147PubMed
184,981,797Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.J Immunol1969https://conductscience.org/library/papers/4981797PubMed
194,267,705Immune complex disease in the kidneys of lymphoma-leukemia patients: the presence of an oncornavirus-related antigen.J Natl Cancer Inst1973https://conductscience.org/library/papers/4267705PubMed
204,340,574Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.Nat New Biol1972https://conductscience.org/library/papers/4340574PubMed
214,136,591Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity.Int J Cancer1974https://conductscience.org/library/papers/4136591PubMed

See all 48 references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
7,379,328Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.Clin Exp Immunol1980https://conductscience.org/library/papers/7379328PubMed
6,606,508Characterization of immune complexes in acute lymphoblastic leukaemia.Clin Exp Immunol1983https://conductscience.org/library/papers/6606508PubMed
6,556,950Nature of antigens and antibodies in immune complexes isolated by staphylococcal protein A from plasma of melanoma patients.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6556950PubMed
6,186,519Suppressor mechanisms in tumor immunity.Experientia1983https://conductscience.org/library/papers/6186519PubMed
6,160,008Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum.Clin Exp Immunol1980https://conductscience.org/library/papers/6160008PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
C3718PubTator's text mininghttps://conductscience.org/library/genes/718

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/748375

GET https://conductscience.org/api/papers/v1/748375/references?page=2